 |
mecasermin, recombinant human insulin-like growth factor-1 |
|---|---|
| Trade Name | Increlex |
| Orphan Indication | Rett like syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-21 00:00:00 |
| Sponsor | Keck Graduate Institute of Applied Life Sciences;535 Watson Drive;Claremont, California, 91711 |
